miércoles, 20 de diciembre de 2017

Prostate Cancer - Dec 18, 2017 Edition

 
 December 18, 2017 
 Prostate Cancer 
 The latest prostate cancer news from News Medical 
 Shorter course of radiation may be preferred treatment for men with intermediate-risk prostate cancerShorter course of radiation may be preferred treatment for men with intermediate-risk prostate cancer
 
Prostate cancer is the most common cancer among males in the United States. Approximately, 180,000 men are diagnosed each year, and approximately 95 percent of these men have localized disease that is potentially curable.
 
 
 PET scans can predict prostate cancer patients’ response to salvage radiation treatmentPET scans can predict prostate cancer patients’ response to salvage radiation treatment
 
For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference.
 
   UVA researchers developing tool to help prostate cancer patients weigh treatment optionsUVA researchers developing tool to help prostate cancer patients weigh treatment options
 
Researchers at the University of Virginia Cancer Center are developing a tool to help patients with prostate cancer better understand the potential risks and rewards of their treatment options.
 
   Prostate cancer researchers find significant disparities between two liquid biopsy providersProstate cancer researchers find significant disparities between two liquid biopsy providers
 
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers.
 
   Researchers adopt new approach to treating advanced prostate cancerResearchers adopt new approach to treating advanced prostate cancer
 
Scientists have proposed a new approach to preventing the proliferation of prostate tumor cells that are no longer responding to treatment. Prostate cancer can usually be cured via surgical removal of the tumor and/or the use of radiotherapy, but in one-fifth of cases, patients also require treatment with drugs to continue removing tumor cells.
 
 Researchers discover new way to attack drug-resistant prostate cancer cells
 
Researchers discover new way to attack drug-resistant prostate cancer cellsIn most cases, prostate cancer is cured by surgical removal of the tumor and/or by radiotherapy. However, 20% of patients will need treatment to remove tumor cells but this treatment ceases to be effective after two or three years and the cancer develops further.
 
 
 Novel ‘black box’ recorder captures surgeons' robotic surgery skills
 
Novel ‘black box’ recorder captures surgeons' robotic surgery skillsYou may know that your surgeon is using the latest minimally invasive technology for your surgery, but how do you know if they've mastered it? To help answer that question, researchers at Keck Medicine of USC looked to a custom recording tool similar in concept to a flight recorder on an airplane.
 
 
 Hidden genes hold blueprints for designing new anti-cancer drugs
 
Hidden genes hold blueprints for designing new anti-cancer drugsNew research suggests these hidden genes hold the blueprints for designing new, even more effective cancer-targeting compounds.
 

No hay comentarios:

Publicar un comentario